Intended for healthcare professionals

CCBY Open access

Rapid response to:

Research

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1931 (Published 27 August 2021) Cite this as: BMJ 2021;374:n1931

Linked Editorial

Strengthening international surveillance of vaccine safety

Rapid Response:

One swallow does not a summer make but perhaps fodder for AstraZeneca to improve their brand image

Dear Editors

One swallow does not a summer make; this study may not be the only research investigating risks of complications related to COVID-19 vaccines side by side with COVID-19 itself, but certainly it may be an important bellwether of findings of future studies in this matter.

Some opponents of vaccination (in general) and those who have COVID-19 vaccine hesitancy may take advantage of these numbers to justify their views, but I have (uncharacteristically) only one comment in response to the findings here:

Astra Zeneca sure needed better media communication specialists, marketing experts and public relations strategists than what they have so far, considering the discrepancy in public concerns and brand damage in response to vaccine-related adverse events connected to ChAdOx1 nCoV-19 when compared to those of “the other vaccine”.

Competing interests: No competing interests

27 August 2021
Shyan Goh
Orthopaedic Surgeon
Sydney, Australia